Amgen’s stock hit by expectations its obesity pipeline is facing a longer wait
October 31, 2023 at 11:59 AM EDT
Amgen Inc.'s stock fell 3.3% Tuesday despite an earnings beat and raised guidance. Obesity drugs were to blame.
Photography by Christophe Tomatis